Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)
Hematologic Neoplasms (Phase 4)
Trials (1 total)
Trial APIs (1 total)